Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current treatment of soft tissue sarcoma.

Literature DB >> 18982082

Current treatment of soft tissue sarcoma.

Shawn Steen¹, Gerald Stephenson.

Abstract

Entities: Disease

Year: 2008 PMID： 18982082 PMCID： PMC2566912 DOI： 10.1080/08998280.2008.11928435

Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN： 0899-8280

× No keyword cloud information.

17 in total

Review 1. Sarcoma and skin radiation oncology.

Authors: Elena Antoaneta Nedea; Thomas F DeLaney
Journal: Hematol Oncol Clin North Am Date: 2006-04 Impact factor: 3.722

Review 2. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors: T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal: Clin Pharmacokinet Date: 2001-01 Impact factor: 6.447

Review 3. Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience.

Authors: I J Spiro; A E Rosenberg; D Springfield; H Suit
Journal: Cancer Invest Date: 1995 Impact factor: 2.176

Review 4. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas.

Authors: Michelle Scurr; Ian Judson
Journal: Hematol Oncol Clin North Am Date: 2005-06 Impact factor: 3.722

Review 5. Surgical management of sarcomas.

Authors: Edward Y Cheng
Journal: Hematol Oncol Clin North Am Date: 2005-06 Impact factor: 3.722

6. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.

Authors: S R Grobmyer; R G Maki; G D Demetri; M Mazumdar; E Riedel; M F Brennan; S Singer
Journal: Ann Oncol Date: 2004-11 Impact factor: 32.976

7. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Authors: William G Kraybill; Jonathon Harris; Ira J Spiro; David S Ettinger; Thomas F DeLaney; Ronald H Blum; David R Lucas; David C Harmon; G Douglas Letson; Burton Eisenberg
Journal: J Clin Oncol Date: 2006-02-01 Impact factor: 44.544

Review 8. Advances in chemotherapy for patients with extremity soft tissue sarcoma.

Authors: Fritz C Eilber; William D Tap; Scott D Nelson; Jeffery J Eckardt; Frederick R Eilber
Journal: Orthop Clin North Am Date: 2006-01 Impact factor: 2.472

9. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Authors: J H Edmonson; L M Ryan; R H Blum; J S Brooks; M Shiraki; S Frytak; D R Parkinson
Journal: J Clin Oncol Date: 1993-07 Impact factor: 44.544

Review 10. The role of radiation therapy in the management of sarcomas.

Authors: Aradhana Kaushal; Deborah Citrin
Journal: Surg Clin North Am Date: 2008-06 Impact factor: 2.741

14 in total

Review 1. Macrophages: The Road Less Traveled, Changing Anticancer Therapy.

Authors: Jennifer L Guerriero
Journal: Trends Mol Med Date: 2018-04-11 Impact factor: 11.951

2. Primary cardiac leiomyosarcoma presenting as haemoptysis in a 22-year-old patient: an unusual presentation of a rare condition.

Authors: Masroor Hassan; Maria Khattak; Hafez Mohammad Ammar Abdullah; Bushra Nasib
Journal: BMJ Case Rep Date: 2017-07-13

Current treatment of soft tissue sarcoma.

Review 1. Sarcoma and skin radiation oncology.

Review 2. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Review 3. Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience.

Review 4. Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas.

Review 5. Surgical management of sarcomas.

6. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.

7. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

Review 8. Advances in chemotherapy for patients with extremity soft tissue sarcoma.

9. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Review 10. The role of radiation therapy in the management of sarcomas.

Review 1. Macrophages: The Road Less Traveled, Changing Anticancer Therapy.

2. Primary cardiac leiomyosarcoma presenting as haemoptysis in a 22-year-old patient: an unusual presentation of a rare condition.

3. The importance of Src signaling in sarcoma.

4. ["Dangerous" cutaneous polyp. Exophytic cutaneous myxofibrosarcoma].

5. Undifferentiated pleomorphic sarcoma: indolent, tail-like recurrence of a high-grade tumor.

Review 6. New therapeutic targets in soft tissue sarcoma.

Review 7. Advances in the targeted therapy of liposarcoma.

8. Verticillin A Inhibits Leiomyosarcoma and Malignant Peripheral Nerve Sheath Tumor Growth via Induction of Apoptosis.

9. Obesity Does Not Exacerbate the Protumorigenic Systemic Environment in Sarcoma Subjects.

10. Effective apatinib treatment of pleomorphic liposarcoma: A case report.